| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fractyl Health, Inc. | Director | Common Stock | 1.86M | $5.38M | $2.90 | Feb 6, 2024 | Indirect |
| Invivyd, Inc. | Director, Other* | Stock Option (Right to Buy) | 50K | May 21, 2024 | Direct | ||
| Fractyl Health, Inc. | Director | Stock Option | 45K | Feb 1, 2024 | Direct | ||
| SQZ Biotechnologies Co | Director | Stock Option | 39.9K | Jun 14, 2023 | Direct | ||
| Fractyl Health, Inc. | Director | Series F Preferred Stock | 0 | Feb 6, 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director, Other* |
| GUTS | Fractyl Health, Inc. | Feb 6, 2024 | 3 | $7M | 4 | Feb 8, 2024 | Director |
| GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | Director |
| GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 0 | $0 | 3 | Feb 1, 2024 | Director |
| SQZB | SQZ Biotechnologies Co | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| IVVD | Invivyd, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director, Other* |
| IVVD | Adagio Therapeutics, Inc. | Aug 17, 2022 | 3 | $12.2M | 4 | Aug 19, 2022 | Director, Other* |
| IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director, Other* |
| SQZB | SQZ Biotechnologies Co | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| IVVD | Adagio Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 3 | Apr 1, 2022 | Other* |
| SQZB | SQZ Biotechnologies Co | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |